These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 6791551

  • 1. Prothrombin complex concentrates: clinical use.
    Menache D.
    Ann N Y Acad Sci; 1981; 370():747-56. PubMed ID: 6791551
    [No Abstract] [Full Text] [Related]

  • 2. Prothrombin complex concentrates for clinical use.
    Chandra S, Brummelhuis HG.
    Vox Sang; 1981; 41(5-6):257-73. PubMed ID: 6798760
    [Abstract] [Full Text] [Related]

  • 3. Prothrombin complex concentrates: preparation, properties, and clinical uses.
    White GC, Lundblad RL, Kingdon HS.
    Curr Top Hematol; 1979; 2():203-44. PubMed ID: 318075
    [No Abstract] [Full Text] [Related]

  • 4. Editorial: Factor VIII inhibitors.
    Deykin D.
    N Engl J Med; 1974 Jul 25; 291(4):205. PubMed ID: 4834491
    [No Abstract] [Full Text] [Related]

  • 5. Four-factor prothrombin complex concentrate for urgent reversal of vitamin K antagonists in patients with major bleeding.
    Quinlan DJ, Eikelboom JW, Weitz JI.
    Circulation; 2013 Sep 10; 128(11):1179-81. PubMed ID: 23935012
    [No Abstract] [Full Text] [Related]

  • 6. Activated prothrombin concentrate for patients with factor VIII inhibitors.
    Kurczynski EM, Penner JA.
    N Engl J Med; 1974 Jul 25; 291(4):164-7. PubMed ID: 4834485
    [No Abstract] [Full Text] [Related]

  • 7. Factor IX complex.
    Aronson DL.
    Semin Thromb Hemost; 1979 Jul 25; 6(1):28-43. PubMed ID: 390713
    [No Abstract] [Full Text] [Related]

  • 8. Use of prothrombin complex concentrates in anticoagulation.
    van Veen SQ, Strengers PF.
    Am J Hematol; 2008 Apr 25; 83(4):344-5. PubMed ID: 18213649
    [No Abstract] [Full Text] [Related]

  • 9. Clinical use of human prothrombin complexes.
    Tullis JL, Melin M, Jurigian P.
    N Engl J Med; 1965 Sep 23; 273(13):667-74. PubMed ID: 5827030
    [No Abstract] [Full Text] [Related]

  • 10. Properties of commercial factor IX concentrates.
    Coan MH, Fournel MA, Mozen MM.
    Ann N Y Acad Sci; 1981 Sep 23; 370():731-46. PubMed ID: 6168231
    [No Abstract] [Full Text] [Related]

  • 11. Preliminary characterization of a "factor VIII bypassing coagulant".
    Aronson DL, Bagley J.
    Ann N Y Acad Sci; 1981 Sep 23; 370():291-302. PubMed ID: 6791547
    [No Abstract] [Full Text] [Related]

  • 12. Human prothrombin complex.
    N Engl J Med; 1965 Sep 23; 273(13):715-6. PubMed ID: 5827038
    [No Abstract] [Full Text] [Related]

  • 13. Prothrombal: a new concentrate of human prothrombin complex for clinical use.
    Bruning PF, Loeliger EA.
    Br J Haematol; 1971 Oct 23; 21(4):377-98. PubMed ID: 5001176
    [No Abstract] [Full Text] [Related]

  • 14. ACP Journal Club. 4F-PCC was noninferior to plasma in patients with acute major bleeding who needed urgent VKA reversal.
    Lang E.
    Ann Intern Med; 2014 Apr 15; 160(8):JC6. PubMed ID: 24733223
    [No Abstract] [Full Text] [Related]

  • 15. Treatment of hemophilia B with a new clotting-factor concentrate.
    Hoag MS, Johnson FF, Robinson JA, Aggeler PM.
    N Engl J Med; 1969 Mar 13; 280(11):581-6. PubMed ID: 5764825
    [No Abstract] [Full Text] [Related]

  • 16. A therapeutic concentrate of coagulation factors II, IX and X from citrated, factor VIII-depleted plasma.
    Middleton SM, Bennett IH, Smith JK.
    Vox Sang; 1973 May 13; 24(5):441-56. PubMed ID: 4691239
    [No Abstract] [Full Text] [Related]

  • 17. Management of Christmas disease and Stuart-Prower deficiency with a prothrombin-complex concentrate (factors II, VII, IX, X).
    Tullis JL, Melin M.
    Bibl Haematol; 1968 May 13; 29():1134-9. PubMed ID: 5700309
    [No Abstract] [Full Text] [Related]

  • 18. [The P.P.S.B. coagulant fraction].
    Soulier JP, Steinbuch M.
    Nouv Presse Med; 1975 Oct 25; 4(36):2581-4. PubMed ID: 812061
    [No Abstract] [Full Text] [Related]

  • 19. [Clinical experience with the PPSB fraction in surgery].
    Frick U.
    Zentralbl Chir; 1972 Feb 05; 97(5):150-3. PubMed ID: 5020589
    [No Abstract] [Full Text] [Related]

  • 20. Therapeutic approaches to factor X deficiency with emphasis on the use of a new clotting-factor concentrate (Konyne).
    O'Leary DS, Ruymann FB, Conrad ME.
    J Lab Clin Med; 1971 Jan 05; 77(1):23-32. PubMed ID: 5540427
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.